Influence of smoking on the efficacy of antimalarials in cutaneous lupus: A meta-analysis of the literature - 14/03/15
Abstract |
Background |
Interaction between smoking and efficacy of antimalarials, the mainstay of treatment for cutaneous lupus erythematosus (CLE), remains controversial.
Objectives |
We systematically reviewed the evidence for such an interaction and performed a meta-analysis to compare the efficacy of antimalarials among smoker versus nonsmoker patients with CLE.
Methods |
Observational studies published up to March 2014 in the MEDLINE, Embase, and Cochrane databases were selected if they reported on the efficacy of antimalarials for treatment of CLE, according to smoking status. The strength of association between smoking and cutaneous response rate was expressed using the odds ratio. Individual study odds ratios were combined in the meta-analysis using a random effects model.
Results |
Of 240 citations retrieved, 10 studies met inclusion criteria, for a total of 1398 patients. The pooled odds ratio for the response to antimalarials in smoker patients with CLE (n = 797) was 0.53 (95% confidence interval 0.29-0.98) compared with nonsmokers (n = 601).
Limitations |
Subgroup analyses for the response to antimalarials considering CLE subtypes, type, and dosage of antimalarials could not be performed because of the lack of available data.
Conclusions |
Smoking is associated with a 2-fold decrease in the proportion of patients with CLE achieving cutaneous improvement with antimalarials. Smoking cessation should be considered in patients with CLE and refractory cutaneous involvement.
Le texte complet de cet article est disponible en PDF.Key words : antimalarials, cutaneous, hydroxychloroquine, lupus erythematosus, smoking, tobacco
Abbreviations used : CI, CLASI, CLE, CQ, HCQ, OR
Plan
| Drs Amoura and Arnaud contributed equally to this work. |
|
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 72 - N° 4
P. 634-639 - avril 2015 Retour au numéro
Article précédent
- The natural history of pediatric-onset discoid lupus erythematosus
- Lisa M. Arkin, Leah Ansell, Alfred Rademaker, Megan L. Curran, Michael L. Miller, Annette Wagner, Brandi M. Kenner-Bell, Sarah L. Chamlin, Anthony J. Mancini, Marisa Klein-Gitelman, Amy S. Paller
- Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: A retrospective case series
- Murat Durdu, Deren Özcan, Mete Baba, Deniz Seçkin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?